Trials / Active Not Recruiting
Active Not RecruitingNCT07248527
PAN-ICIS Study: ICIS for Early Detection of Infectious Complications in Pancreatic Surgery
PAN-ICIS: Prospective Observational Study Evaluating the Intensive Care Infection Score for Early Detection of Infectious Complications After Pancreatic Resections
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Charles University, Czech Republic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study examines a new blood test called ICIS, which may help detect infections earlier after pancreatic surgery. Patients will have routine blood samples taken during their hospital stay, with no extra procedures required. By tracking how ICIS changes over time, investigators aim to improve early infection detection, support safer recovery, and reduce postoperative complications.
Detailed description
Pancreatic resections carry a high burden of postoperative morbidity, particularly due to complications such as pancreatic fistula and bile leakage, which frequently lead to intra-abdominal infection and sepsis. Early diagnosis remains difficult because conventional inflammatory markers (CRP, WBC, PCT, IL-6) lack specificity and are often elevated due to postoperative SIRS. The Intensive Care Infection Score (ICIS) has demonstrated superior performance in distinguishing SIRS from sepsis in surgical patients. The PAN-ICIS study is a prospective observational study enrolling patients undergoing pancreatic resections. ICIS will be measured postoperatively and compared with conventional inflammatory markers. Perioperative variables, postoperative complications, and infectious outcomes will be collected prospectively. Accurate early differentiation between SIRS and sepsis represents a major need in pancreatic surgery. This study will evaluate the diagnostic accuracy and clinical utility of ICIS for early detection of postoperative infectious complications. If validated, ICIS may support earlier antimicrobial therapy, reduce unnecessary antibiotic exposure, and improve postoperative outcomes in this high-risk population.
Conditions
- Pancreatectomy
- Pancreatic Surgery
- Intensive Care (ICU)
- Inflamatory Markers
- Postoperative Care
- Postoperative Pancreatic Fistula
- Surgical Site Infection After Major Surgery
- Postoperative Complications
Timeline
- Start date
- 2025-11-01
- Primary completion
- 2027-12-31
- Completion
- 2028-03-31
- First posted
- 2025-11-25
- Last updated
- 2025-12-01
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT07248527. Inclusion in this directory is not an endorsement.